In the present work, we aimed to explore the beneficial effects of metformin treatment on RNASEH2B- and RNASEH2A-mutated LCLs, specifically focusing on its ability to reduce ROS production and reverse the oxidative stress in LCLs derived from AGS patients. Here, RNASEH2B is linked to Aicardi-Goutieres syndrome.